Publications
Publications
At Bayer, we are working in collaboration with the leading scientific, academic, and community partners to improve our understanding of hemophilia A.
We invite you to explore Bayer-supported publications. This library is not intended to serve as a comprehensive repository of all publications. Publications not supported by Bayer are not included. Access to the full text of publications may depend on journal access rights.
To help narrow down your search, choose the relevant tags and click Apply. Selecting multiple tags will narrow your results.
Last updated May 22, 2024.
Types of Enhancements Available

Plain Language Summary

Infographic
Total available publications: 77
Filtered results: 77
Canadian clinical experience on switching from standard half-life rFVIII, octocog alfa, to extended half-life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
Matino D, et al. Haemophilia. 2024. Mar;30(2):345-354